Cours Rekah Pharmaceutical Industry Ltd. TEL AVIV STOCK EXCHANGE
Actions
REKA
IL0010810096
Produits pharmaceutiques
CA 2022 | 292 M 78,67 M 71,38 M | CA 2023 | 322 M 86,54 M 78,52 M | Capitalisation | 169 M 45,39 M 41,18 M |
---|---|---|---|---|---|
Résultat net 2022 | -2 M -538 k -488 k | Résultat net 2023 | -6 M -1,61 M -1,46 M | VE / CA 2022 | 1,1 x |
Dette nette 2022 | 145 M 39,12 M 35,5 M | Dette nette 2023 | 166 M 44,78 M 40,63 M | VE / CA 2023 | 1,04 x |
PER 2022 |
-85,5
x | PER 2023 |
-24,2
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 17,36% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 80 | 24/08/93 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 01/11/18 |
Director/Board Member | 78 | 24/08/93 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 15/04/15 |
Amiram Boehm
BRD | Director/Board Member | 52 | 15/04/15 |
Avraham Bigger
CHM | Chairman | 77 | 15/04/15 |
Varia. 1 janv. | Capi. | |
---|---|---|
+19,95% | 72,78 Md | |
-2,49% | 24,24 Md | |
+8,80% | 8,59 Md | |
+9,15% | 8,38 Md | |
-17,39% | 8,09 Md | |
+7,33% | 4,81 Md | |
+17,69% | 4,32 Md | |
-3,66% | 4,05 Md | |
-2,54% | 3,93 Md |